174 related articles for article (PubMed ID: 38341456)
21. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
22. OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients.
Viet CT; Dang D; Aouizerat BE; Miaskowski C; Ye Y; Viet DT; Ono K; Schmidt BL
J Pain; 2017 Sep; 18(9):1046-1059. PubMed ID: 28456745
[TBL] [Abstract][Full Text] [Related]
23. How much oxycodone is needed for adequate analgesia after breast cancer surgery: effect of the OPRM1 118A>G polymorphism.
Cajanus K; Kaunisto MA; Tallgren M; Jokela R; Kalso E
J Pain; 2014 Dec; 15(12):1248-56. PubMed ID: 25239082
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
[TBL] [Abstract][Full Text] [Related]
25. A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.
Crist RC; Doyle GA; Nelson EC; Degenhardt L; Martin NG; Montgomery GW; Saxon AJ; Ling W; Berrettini WH
Pharmacogenomics J; 2018 Jan; 18(1):173-179. PubMed ID: 27958381
[TBL] [Abstract][Full Text] [Related]
26. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
27. ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics.
Barratt DT; Coller JK; Hallinan R; Byrne A; White JM; Foster DJ; Somogyi AA
Pharmgenomics Pers Med; 2012; 5():53-62. PubMed ID: 23226062
[TBL] [Abstract][Full Text] [Related]
28. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
[TBL] [Abstract][Full Text] [Related]
29. Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism.
Browne CA; Erickson RL; Blendy JA; Lucki I
Neuropharmacology; 2017 May; 117():401-407. PubMed ID: 28188737
[TBL] [Abstract][Full Text] [Related]
30. Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement.
Matic M; Jongen JL; Elens L; de Wildt SN; Tibboel D; Sillevis Smitt PA; van Schaik RH
Pharmacogenomics; 2017 Aug; 18(12):1133-1142. PubMed ID: 28745577
[TBL] [Abstract][Full Text] [Related]
31. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
[TBL] [Abstract][Full Text] [Related]
32. The μ-opioid receptor nonsynonymous variant 118A>G is associated with prolonged abstinence from heroin without agonist treatment.
Levran O; Peles E; Randesi M; da Rosa JC; Adelson M; Kreek MJ
Pharmacogenomics; 2017 Oct; 18(15):1387-1391. PubMed ID: 28976288
[TBL] [Abstract][Full Text] [Related]
33. OPRM1 and COMT Gene-Gene Interaction Is Associated With Postoperative Pain and Opioid Consumption After Orthopedic Trauma.
Khalil H; Sereika SM; Dai F; Alexander S; Conley Y; Gruen G; Meng L; Siska P; Tarkin I; Henker R
Biol Res Nurs; 2017 Mar; 19(2):170-179. PubMed ID: 27903758
[TBL] [Abstract][Full Text] [Related]
34. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
[TBL] [Abstract][Full Text] [Related]
35. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths.
Bunten H; Liang WJ; Pounder DJ; Seneviratne C; Osselton D
Clin Pharmacol Ther; 2010 Sep; 88(3):383-9. PubMed ID: 20668445
[TBL] [Abstract][Full Text] [Related]
36. The A118G single-nucleotide polymorphism of human μ-opioid receptor gene and use of labor analgesia.
Pettersson FD; Grönbladh A; Nyberg F; Sundström-Poromaa I; Åkerud H
Reprod Sci; 2012 Sep; 19(9):962-7. PubMed ID: 22527985
[TBL] [Abstract][Full Text] [Related]
37. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans.
Fillingim RB; Kaplan L; Staud R; Ness TJ; Glover TL; Campbell CM; Mogil JS; Wallace MR
J Pain; 2005 Mar; 6(3):159-67. PubMed ID: 15772909
[TBL] [Abstract][Full Text] [Related]
38. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
39. The human μ-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients.
Menon S; Lea RA; Roy B; Hanna M; Wee S; Haupt LM; Griffiths LR
J Headache Pain; 2012 Oct; 13(7):513-9. PubMed ID: 22752568
[TBL] [Abstract][Full Text] [Related]
40. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
